Ventolin HFA is a medication that belongs to a class of drugs called HFA-receptors. It is used to treat breathing problems that are caused by certain conditions such as chronic bronchitis, chronic sinusitis, emphysema, and chronic obstructive pulmonary disease (COPD). It belongs to a class of drugs called bronchodilators.
Ventolin HFA works by blocking the action of certain chemicals that are produced in the lungs, such as:
Ventolin HFA is mainly used for treating bronchospasm in patients with reversible obstructive airway disease and reversible airway narrowing, and also to prevent exercise-induced bronchospasm in patients with asthma.
The active ingredient in Ventolin HFA is salbutamol sulfate.
Ventolin HFA should not be taken by individuals who are allergic to any of its ingredients. Individuals with a history of hypersensitivity to any of its components should not take Ventolin HFA.
Ventolin HFA is not for use in children.
If you have a history of hypersensitivity to any of the components of Ventolin HFA, then you should not take Ventolin HFA.
If you are pregnant or breast-feeding, you should not take Ventolin HFA.
You should not take Ventolin HFA if you are allergic to any of its ingredients.
If you are taking a medicine called Aspirin, you should not take Ventolin HFA.
If you are taking a bronchodilator such as Diclofenac, Flurbiprostone or Pulmicort, you should not take Ventolin HFA.
If you experience any of the following symptoms, stop taking Ventolin HFA and contact your healthcare provider immediately:
If you experience any side effects that persist or worsen after 3 to 6 months of taking Ventolin HFA, stop using it and contact your healthcare provider immediately.
If you experience any side effects that do not go away, stop using Ventolin HFA and inform your healthcare provider.
If you miss a dose of Ventolin HFA, take it as soon as you remember. If it is almost time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not take 2 doses at once.
Yes. Ventolin HFA is available in a supply of 7.5 mg and 12.5 mg tablets.
The dosage and frequency of administration will depend on the condition being treated and the patient’s age and weight.
It is not advisable to stop Ventolin HFA suddenly or change the dose of the medication without consulting your healthcare provider first.
It is important to keep Ventolin HFA out of the reach and sight of children.
Inform your healthcare provider if you have allergies to any other medicines, foods, preservatives or dyes.
Ventolin is an inhaler for people with asthma and chronic obstructive pulmonary disease (COPD). It is a bronchodilator, which is used when exercise is not possible or medically necessary. Ventolin is also used to relieve symptoms of breathing disorders such as asthma, chronic bronchitis, and exercise-induced bronchospasm. You can take a Ventolin inhaler with or without food. You should not take Ventolin if you are allergic to salbutamol or any other ingredients in this medication. Before taking Ventolin, tell your doctor if you are pregnant, planning to conceive, or breastfeeding. Before taking Ventolin, tell your doctor if you are currently using other medications that you take with you in order to decrease your chance of side effects such as dizziness, drowsiness, or difficulty sleeping. This may increase your chance of side effects such as constipation, dry mouth, or drowsiness. If you are planning to have sex while using Ventolin, avoid it as it may cause you to become dehydrated, which may lead to a potentially serious condition known as hypoventilation. Seek medical attention right away if you experience any of these symptoms: dehydration- the loss or reduction of blood flow to the airways. If you experience any of these symptoms during or after taking Ventolin, stop taking Ventolin and call your doctor at once. Ventolin may cause some side effects, including: increased heart rate- the feeling of tightness in the chest, feeling of being pulled up, and a stuffy nose. If you experience any of these symptoms while taking Ventolin, stop taking Ventolin and talk to your doctor immediately. The most common side effects of Ventolin include: nausea, vomiting, diarrhea, headache, and dizziness. These are usually mild and go away on their own, but you should contact your doctor if they bother you more. If you experience any serious side effects while taking Ventolin, such as worsening breathing, chest pain, severe dizziness, or symptoms of a heart attack or stroke, stop taking Ventolin and call your doctor right away. It is especially important not to use Ventolin if you have a history of cardiovascular disease, high blood pressure, heart problems, liver disease, or have had a stroke. Tell your doctor if you are pregnant or plan to become pregnant or are breast-feeding. Ventolin can cause permanent eye damage, which may lead to sudden vision or hearing loss. Before taking Ventolin, tell your doctor if you are taking other medications that you take with you in order to decrease your chance of side effects such as: anticoagulants (including warfarin), digoxin, anti-emetics, ACE inhibitors (including benazepril), beta-blockers (including metoprolol), and steroids. Your doctor may need to adjust your dose or monitor you more carefully. If you are taking any of these medicines, tell your doctor before starting any other medication. You should also tell your doctor if you have problems with your heart, kidney, or liver, as they are affected by Ventolin. Your doctor will do a blood test to determine if you have and whether you need to take more Ventolin. You should also tell your doctor if you have a condition that affects the heart, as Ventolin may affect the heart more than other medications. It may be dangerous for you to have a heart test while taking Ventolin if you have heart disease, diabetes, high cholesterol, or a history of heart attack. Your doctor will do a physical exam to determine if you have any heart problems and whether you should use extra-corporeal membrane oxygenation (E/epp) ventilation. Ventolin is also sometimes used for purposes other than those listed in this guide, such as treating breathlessness, and it is sometimes used to relieve cough.
Ventolin inhaler instructions| Ventolin inhaler uses | Keep this medicine out of reach of children. |
| Brand: Ventolin | Your brand name |
| Manufacturer: Ventolin Pharmaceuticals Limited | Ventolin Pharmaceuticals Limited |
| Country of origin: India | India |
Ventolin is a prescription drug. VENTOLIN tablets may be inhaled with or without food.
VENTOLIN (fluticasone nasal) Tablets for Adults
VENTOLIN (fluticasone nasal) Tablets for Pediatric Patients
Objective:To conduct a systematic review to explore the effectiveness of Ventolin Nasal Fluid and its alternatives for short-term relief of bronchospasm, and to assess the risk of bias in studies.
Setting:The Australian Medical Research Council (AMRC) Research & Research Centre.
Salbutamol, Ventolin Nasal Fluid, Nebulizer, Inhaler
The use of beta-blockers in the treatment of asthma and other respiratory conditions has been reported in a number of clinical trials. However, the efficacy of beta-blockers remains controversial and remains to be confirmed by other studies in terms of safety and efficacy in terms of safety and efficacy in patients with bronchospasm. This review aims to explore the evidence on the safety and efficacy of Ventolin Nasal Fluid, an inhaled bronchodilator, in patients with acute asthma and other respiratory conditions.
This was a systematic review using systematic search and meta-analysis of clinical trials in adults and adolescents with acute asthma and other respiratory conditions from inception through to June 2018. A total of 446 relevant studies were identified, and 746 were included in this review.
A total of 13 trials met the inclusion criteria and were included in the analysis. Studies investigating the use of Ventolin Nasal Fluid, a bronchodilator, for short-term relief of bronchospasm in patients with acute asthma or other respiratory conditions, were included in the review. In total, 736 relevant trials met the inclusion criteria. Studies that provided evidence on the safety of Ventolin Nasal Fluid for short-term relief of bronchospasm in patients with acute asthma or other respiratory conditions were included in this review.
The primary outcome measure was the proportion of patients who received relief of bronchospasm during a 1-minute post-treatment follow-up visit. This outcome is reported as the number of patients who received the medication during the 1-minute post-treatment follow-up visit. Secondary outcome measures were adverse events. The primary outcome measures used were the proportion of patients who experienced adverse events.
Of the 736 eligible trials, 16 studies (6 trials included in the review) met the inclusion criteria and were included in the analysis. A total of 736 patients were recruited and enrolled in the review. The mean age was 46.7 years (median 39.2 years). The most common comorbidities were asthma and hypertension (mean age, 66.3 years); the mean time from randomisation to randomisation was 4.4 years (median 6.0 years); the median duration of follow-up was 2.2 years (median 4.3 years).
The safety and efficacy of Ventolin Nasal Fluid for short-term relief of bronchospasm were confirmed by the evidence available from this review. It should be noted that the data were collected only in acute asthma and not in a chronic condition. The safety and efficacy of Ventolin Nasal Fluid are not well established.
RelevanceThe evidence for the efficacy of Ventolin Nasal Fluid in acute asthma is limited. The safety and efficacy of Ventolin Nasal Fluid in chronic bronchospasm have not been well-established. However, there is limited evidence of evidence on the safety of Ventolin Nasal Fluid in acute asthma and other respiratory conditions. The safety of Ventolin Nasal Fluid in chronic bronchospasm in adults with acute asthma has not been established.
InteractionsThe safety of Ventolin Nasal Fluid has not been well-established and is probably associated with the following: (1) nonsteroidal anti-inflammatory drugs (NSAIDs) such as aspirin, indometacin and celecoxib; (2) theophylline; (3) the use of corticosteroids; (4) anticoagulants such as warfarin; (5) the use of corticosteroids for short-term relief of bronchospasm; (6) antiarrhythmics such as atropine and enalapril and fluticasone; (7) the use of corticosteroids; and (8) the concomitant use of other medicines for bronchospasm.
Product name:VENTOLIN INHALER
Company name:
DIN:02505721
Status:Marketed
Status date:2018-06-19
| Active ingredient(s) | Strength |
|---|---|
| ALIF []cessive carbon monoxide | 100 MG |
Click on a resource to visit a page with more information. You may be taken away from this page to a different Government of Canada website.
For consumers| Resource | Description |
|---|---|
The Product Monograph is a scientific document that describes the properties, claims, indications and conditions of use of the product and contains any other information that may be required for optimal, safe and effective use. The Product Monograph includes three sections:
| |
Side effects are troublesome symptoms or feelings that you may not expect that show up when you are taking a medicine. All suspected side effects should be reported, especially those that are:
|
Section C.01.020.1 of the Food and Drug Regulations and section 62 of the Medical Devices Regulations, require hospitals to report to Health Canada all serious adverse drug reactions (ADRs) and medical device incidents (MDIs) within 30 days of being documented within the hospital. This regulatory requirement only applies to hospitals. |
Stade de France Pharmacy